Copyright Pyrite: Regeneran
President Trump is taking a drug he described as a “cure” for Covid-19, and said he would pass it on to the U.S.
The drug uses a combination of antibodies, and was developed by US-based company Regeneron using human cells taken from aborted fetuses.
But the Trump administration suspended funding for projects from abortion to the use of human embryonic tissue in 2019. There is no explicit restriction on the use of embryonic material in drug research.
At the time of the fund’s suspension, the Department of Health and Human Services issued a statement Saying: “Promoting pride from the notion of human life to natural death is a very primary priority of the President Trump administration.”
Questions have been raised about the use of the President and the promotion of new coronavirus treatments that have been developed with the help of practice.
Some vaccine development projects with other drug remedesivir and White House funding used by the president also rely on identical cell lines arising from fetal tissue.
But the policy excluded cell lines formed before June 2019. The cells that most companies are now trying to find coronavirus treatments were taken from aborted fetal tissues in the 1970s.
So the latest drugs being appealed by Trump do not violate existing rules unless they are being made using a cell line from a recently aborted fetus.
